Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors
2013
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI